V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20039320 | 20180850 | 1.84 | 96.9 | null | 2019-12-12 | 2019-12-19 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101592294 |
| 20040998 | 20180851 | 0 | 80.1 | null | 2016-05-24 | 2016-05-31 | null | 02 | null | CAPECITABINE + MITOMYCIN | 101468702 |
| 20042790 | 20180852 | 0 | null | null | 2016-09-11 | 2016-11-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | FLUOROURACIL + MITOMYCIN | 101117493 |
| 20047432 | 20180854 | 0 | null | null | 2020-06-26 | 2020-11-23 | null | 02 | null | LANREOTIDE | 101205070 |
| 20047460 | 20180855 | 1.63 | null | null | 2019-01-10 | 2019-01-20 | Cape+Cisplatin+Trastuzumab Main | 02 | null | HCX | 101234913 |
| 20048023 | 20180856 | 0 | 93.6 | null | 2018-10-16 | 2018-11-09 | LENVATINIB | 02 | null | LENVATINIB | 100262178 |
| 20048993 | 20180857 | 0 | 90.1 | null | null | null | Doxorubicin chemoembolisation | N | null | DOXORUBICIN EMBOLISATION | 100973345 |
| 20050043 | 20180858 | 0 | 77 | Palliative (P) | 2016-09-17 | 2018-01-31 | LANREOTIDE | 02 | N | LANREOTIDE | 100345266 |
| 20052484 | 20180859 | 0 | 61 | null | 2021-08-15 | 2021-08-16 | LANREOTIDE | 02 | null | LANREOTIDE | 101022083 |
| 20052570 | 20180860 | 0 | null | null | 2018-01-06 | 2018-01-07 | LANREOTIDE | 02 | null | LANREOTIDE | 101319743 |
| 20053056 | 20180861 | 0 | 64.2 | null | 2019-01-19 | 2019-02-05 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 101457667 |
| 20062614 | 20180865 | 0 | 61.4 | null | null | 2022-05-12 | null | 99 | null | LENVATINIB | 101647803 |
| 20065637 | 20180866 | 0 | 75.3 | null | 2019-08-19 | 2019-09-25 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100222094 |
| 20069155 | 20180868 | 1.76 | null | Palliative (P) | 2020-10-13 | 2020-11-06 | LANREOTIDE | 02 | N | LANREOTIDE | 101117936 |
| 20073374 | 20180869 | 1.76 | 66.2 | Palliative (P) | null | 2022-04-02 | null | null | N | CARBOPLATIN | 101601864 |
| 20078310 | 20180870 | 1.7 | 58 | Adjuvant (A) | 2017-04-24 | 2017-04-26 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100647413 |
| 20078460 | 20180871 | 1.71 | 70.8 | null | 2021-08-18 | 2021-08-30 | Imatinib 400mg | 02 | null | IMATINIB | 100966912 |
| 20078985 | 20180872 | 1.67 | 78 | Palliative (P) | 2020-02-26 | 2020-02-27 | null | null | N | IMATINIB | 100782911 |
| 20092372 | 20180873 | 1.93 | 80.2 | null | null | 2021-10-16 | REGORAFENIB | 02 | null | REGORAFENIB | 101615191 |
| 20111191 | 20180874 | 1.63 | 92.8 | Palliative (P) | null | 2021-05-08 | null | null | N | PLATFORM TRIAL | 100997276 |
| 20112751 | 20180875 | 1.74 | 57 | null | 2022-02-05 | 2022-02-05 | null | null | null | PLATFORM TRIAL | 101260811 |
| 20121424 | 20180877 | 1.86 | null | Neo-adjuvant (N) | 2020-06-14 | 2020-06-16 | null | null | N | CARBOPLATIN + GEMCITABINE | 100191559 |
| 20122862 | 20180878 | 1.64 | null | null | 2019-07-03 | 2019-08-18 | null | null | null | CARBOPLATIN | 101168979 |
| 20124005 | 20180879 | 1.71 | 94 | null | 2020-04-22 | 2021-02-21 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101570061 |
| 20124470 | 20180880 | 1.7 | 84 | null | 2021-02-23 | 2021-04-14 | null | null | null | CAPECITABINE + TEMOZOLOMIDE | 100368605 |
| 20128425 | 20180881 | 1.65 | 0 | 03 | 2021-02-04 | 2021-02-23 | null | N | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101186030 |
| 20133526 | 20180882 | 1.81 | 0 | Adjuvant (A) | null | 2021-04-07 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101369305 |
| 20134721 | 20180883 | 1.56 | 63.2 | Palliative (P) | null | 2019-08-07 | LU-177 | null | Y | NOT MATCHED | 100284389 |
| 20141745 | 20180884 | 1.81 | 67.2 | Palliative (P) | 2019-09-28 | 2019-12-17 | null | N | N | SUNITINIB | 101465889 |
| 20142915 | 20180885 | 1.61 | 52.9 | null | 2022-04-26 | 2022-04-26 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100097838 |
| 20143370 | 20180886 | null | null | null | 2017-02-21 | 2017-02-21 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100028118 |
| 20148182 | 20180887 | null | 125.8 | Palliative (P) | 2020-01-23 | 2020-01-28 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101627462 |
| 20155475 | 20180889 | null | 61.2 | null | 2021-08-23 | 2021-08-24 | null | 02 | null | EVEROLIMUS | 101204404 |
| 20157177 | 20180890 | 0 | 62.8 | null | 2022-05-17 | 2022-05-20 | null | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 101243634 |
| 20159094 | 20180891 | 1.53 | 57.6 | null | 2022-03-24 | 2022-03-26 | null | 02 | null | LENALIDOMIDE | 101121232 |
| 20169180 | 20180893 | 1.67 | null | null | 2018-03-18 | 2018-03-18 | null | 02 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100813839 |
| 20172887 | 20180895 | 1.66 | 78 | Adjuvant (A) | 2021-12-04 | 2021-12-18 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101667430 |
| 20180926 | 20180897 | 1.55 | 69 | null | null | 2020-02-03 | Bendamustine+Rituximab(Sub Courses) | null | Y | SCOPE2 TRIAL | 100350853 |
| 20184820 | 20180899 | 1.75 | 79.9 | Palliative (P) | 2016-08-14 | 2016-08-22 | DARATUMUMAB | 02 | Y | FLUOROURACIL + RT | 100129984 |
| 20186389 | 20180900 | 1.92 | 63.9 | Adjuvant (A) | null | 2020-08-30 | Doce + Pertuzumab + Trastuz IV Maint | N | null | PERTUZUMAB + TRASTUZUMAB | 101404371 |
| 20194172 | 20180903 | 1.6 | 56 | 03 | 2017-12-16 | 2017-12-29 | ECF | 02 | null | DARATUMUMAB | 100352389 |
| 20197298 | 20180904 | 1.6 | 87.8 | Palliative (P) | 2021-11-01 | 2021-12-22 | ACELARATE Trial | 02 | null | OXALIPLATIN + MDG + PANITUMUMAB | 101227674 |
| 20201166 | 20180905 | 1.69 | 89.6 | Palliative (P) | 2019-06-22 | 2019-06-23 | FEC | 02 | N | TOPOTECAN | 100687744 |
| 20201314 | 20180906 | 1.8 | 104.9 | null | 2018-05-03 | 2018-12-31 | DARATUMUMAB | Y | null | ETOPOSIDE + IFOSFAMIDE | 101256435 |
| 20203204 | 20180907 | 1.8 | 50.8 | Palliative (P) | 2021-03-21 | 2021-03-21 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | GEMCARBO | 101602500 |
| 20206048 | 20180910 | 1.64 | 72.4 | Curative (C) | 2019-05-25 | 2020-02-07 | Carboplatin + Pemetrexed | 02 | null | BORTEZOMIB + RITUXIMAB | 101257517 |
| 20206119 | 20180911 | 1.8 | 98.4 | Adjuvant (A) | 2018-03-08 | 2018-03-08 | Cisplatin + Vinorelbine (PO) | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100637538 |
| 20208450 | 20180914 | 1.65 | 53.2 | Palliative (P) | 2021-01-05 | 2021-01-10 | FOXTROT TRIAL | 02 | null | PAZOPANIB | 101828578 |
| 20211578 | 20180916 | 1.8 | 108.3 | Palliative (P) | 2021-09-14 | 2021-10-06 | TRASTUZUMAB EMTANSINE | 01 | N | TRABECTEDIN | 100774675 |
| 20213191 | 20180918 | null | 69.6 | null | 2022-03-11 | 2022-03-13 | PACLITAXEL + RAMUCIRUMAB | 02 | N | ALECTINIB | 101484197 |